PARALLEL POLYMER-BASED MICROEXTRACTION METHODS TO STUDY INTERMOLECULAR ASSOCIATION AND PHYSICOCHEMICAL PROPERTIES by Lu, Dujuan
  
PARALLEL POLYMER-BASED MICROEXTRACTION METHODS TO STUDY 
INTERMOLECULAR ASSOCIATION AND PHYSICOCHEMICAL PROPERTIES 
 
 
 
 
 
 
 
 
by 
Dujuan Lu 
Bachelor of Science, Nanjing University, 2006 
 
 
 
 
 
 
 
 
 
Submitted to the Graduate Faculty of the 
Kenneth P. Dietrich School of Arts and Sciences in partial fulfillment  
of the requirements for the degree of 
Doctor of Philosophy 
 
 
 
 
 
 
 
 
 
University of Pittsburgh 
2014 
 
 ii 
UNIVERSITY OF PITTSBURGH 
THE KENNETH P. DIETRICH SCHOOL OF ARTS AND SCIENCES 
 
 
 
 
 
 
 
 
This dissertation was presented 
 
by 
 
 
Dujuan Lu 
 
 
 
It was defended on 
July 8
th
, 2014 
and approved by 
Alexander Star, Professor, Department of Chemistry 
Adrian C. Michael, Professor, Department of Chemistry 
Xiang-Qun Xie, Professor, Department of Pharmaceutical Sciences 
 Dissertation Advisor: Stephen G. Weber, Professor, Department of Chemistry 
 
 
 iii 
Copyright © by Dujuan Lu 
2014 
 iv 
 
Lipophilicity and acid dissociation constants are important physicochemical properties 
that in part determine the suitability of an organic molecule as a pharmacological agent. 
Intermolecular associations are omnipresent in chemical and biochemical systems and 
particularly important in the efficacy of an excipient for a poorly soluble drug. Current standard 
methods to determine lipophilicity require large amounts of pure sample and have problems due 
to emulsion formation. This dissertation describes a method based on distribution of the solutes 
between a polymer phase and an aqueous phase in a 96-well format, in the presence and absence 
of a receptor (e.g., candidate excipient) in one of the two phases. This parallel approach uses 
minimal amounts of organic solvent and only requires small amounts of sample. This approach 
has been used to determine polymer-water distribution coefficients of solutes. In addition, by 
measuring polymer-water distribution coefficients at a variety of experimental conditions, such 
as pH and receptor concentration, acid dissociation constants and solute-receptor binding 
constants have been successfully determined for several chemical systems.     
This method has been applied to measure binding constants of econazole with six 
cyclodextrins in aqueous solutions. The acid dissociation constant of econazole was determined 
by measuring econazole-cyclodextrin binding constants at various pH values. Distribution 
coefficients and acid dissociation constants of twenty-four novel drug-like compounds have also 
been determined by this parallel approach and compared to the values calculated by 
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commercially available software. The software packages did not adequately predict experimental 
results, especially for ionizable compounds. This emphasizes the need for laboratory separations-
based measurements of distribution coefficients. The polymeric phase was poly(vinyl chloride) 
(PVC) plasticized by 67% (w/w) dioctyl sebacate (DOS). Intermolecular association has also 
been studied in Teflon AF 2400, a fluorous polymer phase, with and without fluorous hydrogen 
bond donor Krytox 157 FSH in the 96-well approach. In addition, a novel fluorous receptor-
doped fiber solid phase microextraction (SPME) was developed to selectively detect quinoline in 
aqueous solutions.  
 
 vi 
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1.0  INTRODUCTION 
1.1 SOLID PHASE MICROEXTRACTION 
1.1.1 Introduction 
 Sample preparation methods have been developed to clean up the sample matrix and 
preconcentrate target analytes to enhance the measurement signal. Sample preparation is an 
essential step in the analysis process. Over 60% of the total analysis time is spent on preparing 
samples before introducing them into analytical instruments[1]. The success of an analysis of 
samples with a complex matrix also depends on those sample preparation steps. It is necessary to 
develop fast, efficient, and environmentally friendly procedures.  
 Extractions are the most commonly used sample preparation techniques. Extraction is a 
separation process to remove target analytes from a sample matrix. According to the nature of 
the extraction phase, extraction methods can be classified into liquid phase extraction (LPE) and 
solid phase extraction (SPE). Liquid-liquid extraction (LLE) is a widely used method to separate 
compounds based on their distribution between two immiscible liquid phases. This method is 
time consuming and labor intensive, has problems of emulsion formation, and consumes large 
amounts of volatile organic solvents. 
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 A growing concern for protecting the environment has led to an increased emphasis on 
green analytical methods. Solvent-free systems are ideal for preventing hazards to the 
environment and human health. SPE was originally developed as a solvent-free alternative to 
LLE. In SPE, analytes are removed from a flowing sample matrix through sorption to a solid 
phase, which is usually a polymer. A wash solution is chosen to desorb analytes of interest. 
Compared to LLE, SPE has several advantages: high recovery and reproducibility, high 
efficiency with regard to economy of time and labor, and reduction in the amount of organic 
solvents used. 
 Solid phase microextraction (SPME) is a solvent-free extraction technique in which the 
extraction medium is small, usually on a coated fiber or thin film. The process of SPME involves 
two main steps: (1) extraction of the target analyte from the sample matrix to the polymer 
sorbent and (2) desorption of the concentrated analytes from the sorbent to an instrument for 
analysis[2]. Various configurations of SPME have been considered to date, including coated 
fibers, vessels, stirrers, and membranes as illustrated in Figure 1.1[3]. 
 3 
 
Figure 1.1 Various configurations of SPME. The red color describes the extraction phase, which can 
be coated on a fiber, or inside the wall and bottom of a vessel, depending on the configuration. Reproduced 
with permission from reference[3]. Copyright (2011) American Chemical Society. 
1.1.2 SPME theories: from distribution to kinetics 
Both distribution coefficient (D) and partition coefficient (P) between the polymer phase 
and the aqueous phase can be used to describe extraction efficiency of SPME. They are defined 
as the ratio of equilibrium concentrations (C) of an analyte in two immiscible phases. However, 
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there is a clear distinction between those two concepts. Partition coefficient (P) reflects the 
concentration ratio of the neutral species only, while the distribution coefficient (D) counts for 
both neutral and ionized species.  
For ionizable compounds, D should be used instead of P in the pH range where ionic 
species exist. In practice not only neutral molecules but also ion pairs may partition. The 
distribution of the neutral and ionized forms of the solute between the polymer film phase and 
the aqueous phase is determined by the distribution coefficient Dpw: 
                      AqAq
ff
pw
SS
SS
D
][][
][][





                                                      Equation 1.1 
where [S]Aq and [S]f are the concentrations of the neutral solute in the aqueous phase and film 
phase, respectively; [S
-
]Aq and [S
-
]f are the concentrations of the ionized solute and its ion pair in 
the aqueous phase and film phase, respectively.  
The partition coefficient (P) for the neutral form of the solute is defined as: 
                             Aq
f
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S
S
P
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                                                                     Equation 1.2 
The conditional partition coefficient for the anionic solute in the presence of a particular set of 
counterions at certain concentrations is defined as: 
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
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                                                                      Equation 1.3 
It is known that the equilibrium equation for acid dissociation constant Ka is  
                              Aq
Aq
a
S
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K
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][][ 
                                                                  Equation 1.4 
Inserting Equation (1.2), (1.3), and (1.4) into Equation (1.1), yields: 
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         Equation 1.5 
By plotting Dpw versus pH, the Ppw, Ppw
-
 and pKa values of the ionizable solute can be obtained 
by applying a nonlinear least-squares curve fitting according to Equation (1.5). When only single 
neutral species exists, partition coefficient (P) and distribution coefficient (D) are identical.  
Coated fiber SPME is the most widely used SPME configuration. It is performed by 
either direct or headspace extraction. In the direct extraction mode, the coated fiber is inserted 
into the sample matrix to extract analytes into the extraction phase. In the headspace extraction 
mode, the fiber is inserted into the gaseous headspace above the sample matrix to extract 
relatively volatile analytes. Headspace SPME is a multiphase distribution process that includes 
three phases: sample matrix, the gaseous headspace, and the fiber coating. During the extraction, 
analytes partition between all three phases. Direct extraction can be considered as a simpler case 
(no headspace) of three phase distribution. It is important to understand the distribution and mass 
transfer processes of the extraction. 
The amount of an analyte extracted by the polymeric coating is related to the overall 
distribution of the analyte in the multiphase system. The total mass of an analyte remains 
constant during the extraction: 
sshhffs VCVCVCVC 0                                                 Equation 1.6  
where C0 is the initial concentration of the analyte in the sample matrix, Cf, Ch, and Cs are the 
concentrations of the analyte in the polymeric fiber coating, the headspace and the sample, 
respectively, and Vf, Vh and Vs, are the volumes of the polymeric fiber coating, the headspace, 
and the sample, respectively. Note that here we assume only single neutral species is present in 
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each phase to simplify the discussion. In most applications, the experimental conditions can be 
tuned so that the neutral species dominates. 
The film-headspace partition coefficient Pfh is then defined as: 
h
f
fh
C
C
P                                                                     Equation 1.7 
The headspace-solution partition coefficient Phs is defined as: 
s
h
hs
C
C
P                                                          Equation 1.8 
Thus, the film-solution partition coefficient Pfs is described as: 
hsfhfs PPP        Equation 1.9  
The amount of analyte extracted n is defined as: 
ff VCn       Equation 1.10 
Combing Equation (1.7), (1.8), (1.9), and (1.10), yields: 
shhsffs
sffs
VVPVP
CVVP
n


0
     Equation 1.11 
where Pfs is the partition coefficient of the analyte between the fiber coating and the sample 
matrix. If there is no headspace in the sample vial (direct liquid extraction), the term PhsVh in the 
denominator can be eliminated, resulting in: 
sffs
sffs
VVP
CVVP
n


0
     Equation 1.12 
For large sample volumes, when PfsVf  << Vs, Equation (1.12) can be simplified to  
0CVPn ffs       Equation 1.13 
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The above equations show that the amount of the analyte extracted depends on its partition 
coefficient between the sample matrix and the sorbent phase, the volumes of the extraction phase 
and sample matrix, and the initial concentration. 
 The partition coefficients between the extraction phase and the sample matrix depend on 
a variety of conditions, including temperature, pressure, and exact matrix composition. 
Temperature effects need to be considered when temperature changes during the extraction 
procedure. When the temperatures of both the fiber and sample matrix change from T0 to T, the 
partition coefficient changes according to the following equation (assuming the changes in 
entropy and enthalpy are independent of temperature)[4]: 















0
0
11
exp
TTR
H
PP
o
fs     Equation 1.14 
where P0 is the partition coefficient at temperature T0, ∆H
o
 is the molar enthalpy change of the 
analyte from the sample matrix to fiber coating, and R is the gas constant.   
Figure 1.2 shows a typical SPME extraction kinetics profile. There is a quick increase in 
the extracted amount of analyte right after the contact of the fiber with the sample. The rate then 
decreases and equilibrium is eventually achieved. The profile is approximately linear in the 
beginning of the kinetic process. 
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Figure 1.2 Typical extraction time profile of SPME. Reprinted with permission from reference[5]. 
Copyright (2007) Elsevier. 
 The use of the headspace (HS) extraction speeds up the extraction process. For volatile 
compounds, a big portion of the analyte is already in the headspace before the extraction. 
Diffusion coefficients are usually 4-5 orders of magnitude larger in the gas phase than in the 
liquid phase[3]. Therefore, HS-SPME results in faster equilibration than liquid-phase SPME 
(direct liquid extraction). 
The kinetics of analyte from the sample matrix into a SPME coating for large sample 
volumes can be described by [6,7]: 
                                   0)]exp(1[ CVPtan ffs                                                 Equation 1.15 
where n is the amount of analyte extracted, Pfs is the partition coefficient of the analyte between 
the fiber coating and the sample matrix, Vf is the volume of extraction phase, and C0 is the initial 
concentration of the analyte, t is the exposure time, a is a parameter measuring how fast 
equilibrium can be reached, which is a constant for a constantly agitated system. The amount of 
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analyte extracted is proportional to the initial analyte concentration once the sampling time and 
agitation conditions are held constant. Therefore, the quantitative analysis of SPME is feasible 
before partition equilibrium is reached. 
1.1.3 Receptor-doped polymer coating materials as SPME sorbents 
 The selection of polymer coating material is the most important step in controlling the 
selectivity of the extraction[8]. The most common fiber materials are polydimethylsiloxane 
(PDMS), divinylbenzene (DVB), polyacrylate (PA), Carboxen (CAR; a carbon molecular sieve) 
and Carbowax (CW; polyethylene glycol). Coatings of blended materials are also available, such 
as PDMS-DVB, PDMS-CAR, CW-DVB[9]. However, there is no universal sorbent for all 
applications. 
One of the recent trends in SPME is to study new coatings with higher extraction 
efficiency and selectivity[9]. The recently developed coatings for selective extraction include 
molecularly imprinted polymer[10-18], ionic liquid[19-23], metal complex[24], and carbon 
nanotubes[25,26]. 
 Receptors are potentially very powerful tools for selective extractions by taking 
advantage of a specific interaction between a receptor and a substrate through noncovalent 
bonding, such as hydrogen bonding, metal coordination, π-π interactions, hydrophobic forces, 
van der Waals, electrostatic effects, and steric effects[27]. 
When a receptor is present either in the polymer phase or in the aqueous phase, the 
stoichiometry and binding constant of solute-receptor complexation can be determined by 
measuring distribution coefficient of the solute at various receptor concentrations. If a receptor is 
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added into the polymer film phase, solute and receptor forms a complex and the binding constant 
is defined as: 
                                                     
n
ff
fn
n
LS
LS
K
][][
][
:1

                                                              Equation 1.16 
where n is the stoichiometry, [L]f is the free receptor concentration and fnLS ][   is the solute-
receptor complex concentration in the polymer phase. The apparent solute distribution 
coefficient Dapp with the presence of a receptor in the polymer phase is: 
   
aq
fnf
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S
LSS
D
][
][][ 
     Equation 1.17 
Dividing Equation (1.17) by Equation (1.2):  
   
f
fn
pw
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S
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P
D
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1

      Equation 1.18 
After rearranging Equation (1.18) and inserting it into Equation (1.16), we obtain: 
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After converting Equation (1.19) into the logarithmic form and rearranging it, we get  
    fn
pw
app
LnK
P
D
]log[log1log :1 







    Equation 1.20 
The stoichiometry n and binding constant K1:n can be determined by measuring distribution 
coefficient as a function of receptor concentration. 
Our group has done a great deal of work combining molecular recognition processes with 
separation and sample preparation methods. Li and coworkers[28] have reported an SPME 
device based on plasticized-poly (vinyl chloride) (PVC) extraction medium coupled with 
molecular recognition. They incorporated a phenobarbital receptor into a plasticized PVC film 
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coated on a primed steel rod and followed the sampling with micro back-extraction for capillary 
electrophoresis-based determination as shown in Figure 1.3. Such receptors are potentially very 
powerful tools for selective extractions by taking advantage of noncovalent bonding between a 
receptor and an analyte.  
 
Figure 1.3 SPME device and operation. (1) Place rod in sample solution for a designated time. (2) 
Injection 5 µL of back extraction solution into the Teflon tube. (3) Remove rod, wipe clean, place in Teflon 
tube. (4) Remove after a set time (5) Collect the solution by moving the droplet spanning the diameter as a 
piston and transfer the drop to an injection vial. Reprinted with permission from reference[29]. Copyright 
(1997) American Chemical Society. 
1.1.4 Parallel design and automation of SPME 
 High-throughput screening (HTS) has recently become a hot method for scientific 
experimentation. The key testing vessel of HTS is the microplate: a small, usually disposable, 
plastic container that features a grid of small wells. Modern microplates for HTS generally have 
96, 384, or other multiples of 96 wells. Automation is another important characteristic. HTS is a 
relatively recent innovation, made available through modern advances in robotics and high-speed 
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instruments. Since 1990, pharmaceutical and biotechnology companies have gradually moved 
toward HTS of small-molecule compounds for their discovery programs[30].  
 The automation of SPME in parallel format allows significant reduction in analysis time 
and increase in sample throughput. The automation of SPME for the analysis of volatiles and 
semi-volatiles started in 1992 when a Varian Model 8100 autosampler was adapted for the 
analysis of benzene, toluene, ethyl benzene, and xylene[4]. The idea of using multi-fiber SPME 
and desorption on a 96-well microplate format was initially introduced in 2005[31]. This idea 
was appealing for SPME-LC applications, as extraction and desorption are the most time-
consuming steps due to slow mass transfer in the liquid phase. In SPME-LC, after extraction of 
analytes from the sample onto the fibers, the analytes can be desorbed from the fibers using 
liquid desorption, and then injected into a High-Performance Liquid Chromatography (HPLC) 
system. Each fiber is aligned to the corresponding well of a 96-well microplate. Agitation 
method including magnetic stirring, mechanical shaking, and sonication can be used to speed up 
the equilibrium between the SPME fibers and well contents in the microplate.  
The design of parallel format and automation was achieved by introducing a 
commercially available automated sample preparation station called Concept 96 robotic system, 
made by PAS Technology (Magdala, Germany)[32,33]. The automated system consisted of a 
three-arm robotic autosampler that was fully controlled with software and two orbital agitators, 
as shown in Figure 1.4. This design has been applied to analyze drug compounds[33,34], 
polycyclic aromatic hydrocarbons (PAHs)[35], as well as fungal toxins[32] in biological fluids 
and other media [36].  
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Figure 1.4 (a) 96-well multi-fiber SPME device (stainless steel fibers coated with carbon tape). (b) 
robot arm inserting the multi-fiber SPME device in the 96-well plate. Reprinted with permission from 
reference[32]. Copyright (2008) Elsevier. 
1.2 METHODS FOR MEASUREMENT OF ACID DISSOCIATION CONSTANT 
The acid dissociation constant, expressed as the pKa value, is a fundamental property of 
weak acids and bases. For compounds with a single ionized group, it is defined as the pH at 
which a compound is 50% ionized. Once the pKa value is established, the extent of ionization at 
any pH for that compound is easily calculated. This is an important property for 
pharmaceutically active molecules since the physical, chemical, and biological properties of the 
neutral and ionized drugs are generally different. To measure pKa values, it is necessary to put 
the sample in environments of various pH values and monitor a particular property that changes 
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as a function of the ionization state of the molecule. Traditional methods used to determine pKa 
values usually rely on potentiometry or spectroscopy. 
Historically, potentiometric titration is the standard method for the determination of pKa 
values. In this method, the sample is titrated with an acid or base using a pH electrode to monitor 
the course of the titration. Spectrophotometric titrations are generally considered the main 
alternative to potentiometric titrations for pKa measurements. The spectroscopic approach to pKa 
measurement is commonly performed by NMR spectroscopy[37] or UV absorption[38]. The 
former technique analyzes chemical shift values as a function of pH in terms of a single titration 
curve to determine pKa. The NMR method is relatively accurate and reliable but requires 
expensive and sophisticated instrumentation. The latter technique has high sensitivity for 
compounds with favorable molar absorptivity[39]. In this case, however, a chromophoric center 
must exist in the sample close to the ionizable groups so that the neutral and ionized forms show 
sufficiently different UV absorbances. Capillary electrophoresis (CE) has also been proposed as 
a technique for convenient and precise determination of aqueous pKa[40,41]. This method relies 
on the principle that the solute shows an electrophoretic mobility relationship with pH values. In 
its uncharged state, the solute has no mobility, while in its completely ionized state, it has a 
maximum mobility. Acid dissociation constants can be determined by regression analysis of plot 
of mobility with pH values. This method offers several attractive features: it only requires small 
amounts of sample, is highly automated, and does not require precise information of sample 
concentration but only migration times.  
In this dissertation, acid dissociation constant of ionizable compounds has been 
determined by a parallel polymer-based microextraction method. It measures acid dissociation 
constant while measuring intermolecular binding constants or other physicochemical properties 
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including lipophilicity as a function of pH. This parallel approach uses small amounts of sample 
and minimal amounts of organic solvent. 
1.3 METHODS FOR LIPOPHILICITY MEASUREMENT 
Lipophilicity is described by either partition coefficient (P) or distribution coefficient (D), 
which is a measure of how well a molecule partitions between a lipid and water. As discussed in 
Session 1.1.2, P and D are identical if only neutral species are considered. As suggested by 
Collander[42] and Leo[43], log Pow, the logarithmic value of the 1-octanol/water partition 
coefficient, has been widely recognized in the pharmaceutical, biomedical, and environmental 
fields to describe lipophilicity of various compounds. Many experimental methods exist to 
measure log Pow values.  
Traditionally, the shake-flask procedure is a standard method to determine log Pow in the 
range of -2 to 4 [44]. In this method, the substance of interest is introduced into a separatory 
funnel with the two phases (1-octanol and water). The funnel is then shaken for a period long 
enough to reach equilibrium. The concentration of the test substance in each phase is determined 
after phase separation and log Pow is calculated. This method is time consuming, labor intensive, 
and requires relatively large amounts of pure compounds[45,46]. In addition, the octanol/water 
emulsions can be severe problems for compounds having a log Pow value larger than 4 [40,45]. 
The HPLC method is an indirect way to estimate log Pow values in the range of 0-6 and 
has also become a standard method[47]. A series of reference compounds are injected into a C18 
column. The retention factors of those compounds are used to create a calibration curve with 
their known log Pow values. Compounds with unknown Log Pow values are then injected, and 
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their log Pow can be predicted by their retention time from the calibration curve[48]. This 
technique is rapid, precise and reproducible for sets of similar compounds, although impurities 
may make interpretation of the results difficult due to uncertainty in peak assignments. The 
reference compounds should be preferably similar to those being studied and difficulties arise if 
suitable standards are unavailable. One further disadvantage with this method is that HPLC is 
less suitable for molecules in ionic form since charged molecules have a far more complex 
retention behavior[45].  
Recent advances in combinatorial technology have encouraged the development of 
lipophilicity measurement methods to be rapid, high throughput, and operational on the micro-
scale. To increase the throughput of log Pow measurement, an attempt has been made to transfer 
the traditional shake-flask method to a 96-well format.[49] However, restrictions of the shake-
flask method still remained due to octanol/water emulsions. Most of the current experimental 
methods only measure partition coefficients of the neutral species. Novel methods are needed 
with capability of measuring distribution coefficients and extension of applicable log Pow range. 
1.4 OUTLINE 
Lipophilicity and acid dissociation constants are important physicochemical properties 
that in part determine the suitability of an organic molecule as a pharmacological agent. 
Intermolecular associations are omnipresent in chemical and biochemical systems and 
particularly important in the efficacy of an excipient for a poorly soluble drug. Current standard 
methods to determine lipophilicity require large amounts of pure sample and have problems due 
to emulsion formation. This dissertation describes a method based on distribution of the solutes 
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between a polymer phase and an aqueous phase in a 96-well format, in the presence and absence 
of a receptor (e.g., candidate excipient) in one of the two phases. Figure 1.5 illustrates the 
general experimental design of this parallel approach. Briefly, polymer films are first prepared in 
96-well microplates. Aqueous buffered solutions are then dispensed into the microplates. A 
solute or receptor can be embedded in either the polymer phase or the aqueous phase.  
This parallel approach uses minimal amounts of organic solvent and only requires small 
amounts of sample. This approach has been used to determine polymer-water distribution 
coefficients of solutes. In addition, by measuring polymer-water distribution coefficients under a 
variety of experimental conditions, such as pH and receptor concentration, acid dissociation 
constants and solute-receptor binding constants have been successfully determined for several 
chemical systems.     
Chapter 2 of this dissertation focuses on using this parallel approach to determine drug-
cyclodextrin binding constants. Drug and Cyclodextrin form inclusion complex in the aqueous 
solutions. Distribution coefficients of drugs between the polymer phase and the aqueous phase 
have been used to measure binding constants of drug-cyclodextrin inclusion complex. The 
polymeric phase was poly(vinyl chloride) (PVC) plasticized by 67% (w/w) dioctyl sebacate 
(DOS). Binding constants of a poorly water-soluble drug, econazole, with six cyclodextrins in 
aqueous solutions have been measured. The acid dissociation constant of econazole was also 
determined by measuring econazole-cyclodextrin binding constants at various pH values.  
Chapter 3 describes the application of this parallel design to screen distribution 
coefficients of novel drug-like compounds. Distribution coefficients and acid dissociation 
constants of twenty-four novel drug-like compounds have been determined by this parallel 
approach and compared to the values calculated by commercially available software. The 
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software packages did not adequately predict experimental results, especially for ionizable 
compounds. This emphasizes the need for laboratory separations-based measurements of 
distribution coefficients. The polymeric phase was also PVC plasticized by 67% (w/w) DOS.  
Finally, in chapter 4, intermolecular association has been studied in Teflon AF 2400, a 
fluorous polymer phase, with and without fluorous hydrogen bond donor Krytox 157 FSH in the 
96-well approach. We found that the addition of a fluorous carboxylic acid (Krytox 157 FSH) to 
a fluorous film (Teflon AF 2400) increased the polymer-water distribution coefficients of 
quinoline, a nitrogen heterocycle. In addition, a novel fluorous receptor-doped fiber solid phase 
microextraction (SPME) was developed to selectively detect quinoline in aqueous solutions. 
Compared to a commonly used SPME fiber made of polydimethylsiloxane (PDMS), it showed a 
preference for the nitrogen heterocyclic compound over a non-heterocyclic control, phenol. To 
our knowledge, this is the first reported receptor-doped fluorous SPME. 
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Figure 1.5 General procedure of the parallel experimental design to study intermolecular association 
and physicochemical properties 
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2.0  DETERMINATION OF DRUG-CYCLODEXTRIN BINDING CONSTANTS BY A 
HIGH-THROUGHPUT PHASE-DISTRIBUTION METHOD 
Part of this chapter has been published in J. Pharm. Sci., 2009, 98, 229. Reproduced with 
permission from  J. Pharm. Sci.. Copyright (2009) John Wiley & Sons. 
2.1 INTRODUCTION 
Aqueous solubility is one of the fundamental determinants in developing new chemical 
entities as successful drugs.[50] According to recent estimates[51,52], nearly 40 % of new drugs 
are rejected because of poor biopharmaceutical properties. The main biopharmaceutical 
properties include solubility, stability, pKa, bioavailability, brain penetration, and hepatotoxicity. 
Solubility, especially aqueous solubility is the most important one. Low aqueous solubility can 
limit drugs’ function on human bodies. Compounds with an aqueous solubility of less than 100 
µg/mL may require development of a special formulation to overcome poor absorption 
properties.[53]  
To solve this problem, pharmaceutical companies are giving strategies to measure, 
predict and improve solubility of promising new drug candidates during the preclinical phases of 
drug development. Multiple formulation techniques exist to increase the apparent solubility of 
lipophilic compounds without decreasing their optimized potency. These techniques include 
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particle size reduction, pH adjustment, addition of solubilizing excipients, solid dispersion, 
microemulsification, nanocrystallization, inclusion complex formation, etc[54].  
Cyclodextrins (CDs) are bucket-shaped oligosaccharides produced from starch, with a 
hydrophilic outer surface and a lipophilic inner cavity. They can form water-soluble inclusion 
complexes with many lipophilic compounds. They are commonly used in pharmaceutical 
formulations to enhance drug solubility, stability and bioavailability.[55,56] To date, there are 
more than 20 marketed drugs that contain CDs,[57] and numerous publications are emerging 
every year studying the use of CDs for drug formulation and delivery. Although higher order 
complexes are not uncommon, the simplest and most frequent stoichiometry of drug-
cyclodextrin (S-CD) complexes is 1:1 
S + CD
K1:1
S-CD
 
The binding constant (K1:1) is defined as 
]][[
]-[
1:1
CDS
CDS
K                         Equation 2.1 
where [S], [CD], [S-CD] are the concentrations of the free drug, free CD, and drug-CD complex, 
respectively. For consecutive complexation 
S-CDi-1 + CD
K1:i
S-CDi  
The binding constant (K1:i) is defined as  
]][-[
]-[
1
:1
CDCDS
CDS
K
i
i
i

                                                              Equation 2.2 
The binding forces within the drug-CD complexes may involve hydrophobic, van der 
Waals, hydrogen bonding, or dipole interactions.[58] Depending on the cavity size and 
functional groups, CDs vary in their ability to form inclusion complexes with specific guest 
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compounds.[59] The stoichiometry and binding constant are important in any investigation to 
assess the value of a CD for the formulation of a specific drug.[60]  
Various techniques exist to measure drug-CD binding constants. The most common 
method to determine K1:1 for drug-CD binding is the Higuchi-Connors phase-solubility 
method.[61] This method measures the effect of CD concentration on the apparent solubility of 
the drug. The intrinsic solubility (S0) and the slope of the solubility versus CD-content diagram 
are then used to calculate K1:1. There are also a few reports using phase-distribution methods to 
determine binding constants for CD complexes.[62,63] 
Recently, we have developed a high-throughput method that can determine the 
distribution behavior of drug candidates between a polymer phase and an aqueous phase.[27] 
This method has also been applied to measure intermolecular associations in the polymer phase 
to screen chiral selectors.[64] In this chapter of work, we report the application of this high-
throughput method for the determination of drug-CD binding constants in the aqueous phase. 
The polymer phase is composed of poly (vinyl chloride) (PVC) and dioctyl sebacate (DOS) at 
the ratio of 1:2 (w/w). Econazole (Figure 2.1) is an anti-fungal drug, which has very low aqueous 
solubility of 5 µg/mL at 25 
0
C. Its ability to form water-soluble complexes with various CDs was 
determined.  
O
ClCl
N N
Cl  
Figure 2.1 Structure of econazole 
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2.2 EXPERIMENTAL 
2.2.1 Materials  
(2-hydroxyethyl)-β-cyclodextrin (HE-β-CD), (2-hydroxypropyl)-β-cyclodextrin(HP-β-
CD), 2,6-di-O-methyl-β-cyclodextrin(DM-β-CD), heptakis (2,3,6-tri-O-methyl)-β-cyclodextrin 
(TM-β-CD), α-cyclodextrin(α-CD), β-cyclodextrin(β-CD) were purchased from Sigma-Aldrich-
Fluka with the highest available purities. Econazole free base was purchased from Molecula Ltd. 
(Dorset, UK). HPLC grade tetrahydrofuran (THF) and acetonitrile (ACN) were purchased from 
Aldrich (Milwaukee, WI). PVC (high molecular weight) and dioctyl sebacate (DOS) were 
purchased from Fluka (Ronkonkoma, NY). Water used in all the experiments was purified with a 
Milli-Q Synthesis A10 system (Millipore, Bedford, MA). Costar polypropylene 96-well 
microplates (flat-bottom, 330-µL well volume) and thermal adhesive sealing films were 
purchased from Fisher Scientific Co. (Pittsburgh, PA). 
2.2.2 Equipment  
  An UltraSpense 2000 microplate dispenser (KD Scientific, Holliston, MA) was used to 
prepare polymer films in 96-well plates. A Zipvap-96 well evaporator (Chrom Tech, Apple 
Valley, MN) was used to evaporate THF. A Deep Well Maximizer (or BioShaker) (Model 
M·BR-022 UP, made by Taitec and distributed by Bionexus, Inc., Oakland, CA) was used to 
speed up the drug distribution kinetics and control the temperature for better reproducibility. An 
X-LC (Jasco, Inc.) UHPLC system was used to determine the econazole concentration with a 
UHPLC C18 column (1.0 × 50 mm, particle size: 1.7 µM, Waters, Milford, MA).  
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2.2.3 Buffer Preparation 
  The phosphate buffer solutions (20 mM, pH 5.80, 6.62, 6.83, 7.12, 7.43, 8.46) were 
made by mixing appropriate amounts of 20 mM sodium phosphate dibasic solution and 20 mM 
sodium phosphate monobasic solution.  
2.2.4 Preparation of Plasticized PVC Films 
PVC (4.17 g) and DOS (8.33 g) were dissolved in 500 mL of THF in a volumetric flask. 
The microplate dispenser was used to dispense the solution to the wells of a polypropylene 96-
well microplate. The plate was placed in an evaporator for 15 min for evaporation of the THF, 
and the films were formed at the bottom of each well. The volume of each film was estimated as 
L
L
V
d
VmLg
V solution
film
solution
film 

5.2
100
500/5.12


                Equation 2.3 
Here Vsolution is the volume of the THF solution used in each well, and dfilm is the density of the 
film which is estimated as 1 g/mL. In our experiments in this part of work, 100 µL of the THF 
solution was dispensed in each well, so the volume of each film was ~2.5 µL.  
2.2.5 High-Throughput Phase-Distribution Studies 
  Figure 2.2 gives the sequence of operations for the phase-distribution method that 
measures the binding constants of drug-CD complexes. The plasticized PVC films were prepared 
in polypropylene 96-well microplates. Briefly, an appropriate amount of the DOS-plasticized 
PVC THF solution and the drug THF solution are mixed at a ratio of 1:1. Aliquots of 200 µL of 
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this solution were dispensed by the microplate dispenser to microplates. Evaporation of solvent 
allowed the formation of polymer films at the bottom of each well. The volume of each film has 
been calculated to be ~2.5 µL according to Equation 2.3. CD-containing aqueous buffers (200 
L) were then manually dispensed over the films. The plates were covered by adhesive sealing 
films and incubated in a shaker (500 rpm, 25 ºC). In order to determine the equilibration time, 
the concentration of drug extracted into the aqueous phase was measured as a function of time at 
pH 7.4. Other than for this experiment, all data generated were at equilibrium. To determine the 
drug concentration, the supernatant from each well was transferred to another plate and injected 
to the HPLC system by an autosampler. The distribution ratio of concentrations in the aqueous 
phase over the polymer phase, was then calculated as 
             
  

ES
E
wp
CC
C
D                                                                        Equation 2.4 
Here CS is the drug aqueous concentration if all the target has been extracted to the aqueous 
phase, CE is the drug aqueous concentration at equilibrium, and Φ is the phase ratio (aqueous 
over polymer). 
 
Figure 2.2 Schematic illustration of the preparation and use of polymer films in 96-well plates 
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2.2.6 HPLC Method to Determine Econazole Concentration 
  The column used was the Waters UPLC C18 column. The mobile phase was 
acetonitrile/H2O (65/35, v/v), with a flow rate of 0.2 mL/min. The back-pressure was ~7000 psi. 
To ensure reproducibility, the full-load injection mode was used (injection volume 10 µL; loop 
volume 5 µL). Detection was by UV absorbance at 210 nm. The peak area was used for the 
calibration and determination of sample concentration. The time per analysis is ~60 s. 
2.2.7 DOS binding to CDs. 
A 2.5 mL solution of 10 %( w/v) HP--CD was equilibrated with pure DOS for one day 
at 25 
o
C. HPLC of the aqueous phase (UPLC C18 column, mobile phase 90% acetonitrile, 10% 
water, flowing at 0.13 mL/min) showed no obvious DOS peaks. A standard of DOS had a 
retention time of 1.7 minutes. Detection was at 210 nm (absorbance). 
2.3  RESULTS AND DISCUSSION 
2.3.1 Theories to Determine the Stoichiometry n and Binding Constants K1:i  (i = 1 to n) 
  The distribution of the free drug between the aqueous phase and the film phase is determined by 
the distribution coefficient D0: 
filmS
S
D
][
][
0                                     Equation 2.5 
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where [S] and [S]film are the free drug concentration in the aqueous phase and film phase, 
respectively. When the CD is added to the aqueous phase, the drug distribution coefficient is: 
film
n
i
i
S
CDSS
D
][
][][
1



                          Equation 2.6 
where n is the stoichiometry, [S-CDi] (i = 1 to n) is the drug-CD complex concentration in the 
aqueous phase in various forms. Dividing Equation (2.6) by Equation (2.5):  




n
i
i
S
CDS
D
D
10 ][
][
1                                Equation 2.7 
From Equation (2.2), one obtains: 


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i
j
j
i
i KCDSCDS
1
:1]][[][                            Equation 2.8 
Inserting Equation (2.8) to Equation (2.7): 
 
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

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j
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i KCD
D
D
1 1
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][1                               Equation 2.9 
It is known that pKa of econazole is 6.69.[48] If system is acidic, the cationic form of econazole 
should also be considered in the equation as follows. The distribution of the free neutral and 
cationic drug between the aqueous phase and the film phase is determined by the distribution 
coefficient D0, 
filmfilm HSS
HSS
D
][][
][][
0 



                          Equation 2.10 
where [HS
+
] and [HS
+
]film are the free neutral and cationic drug concentration in the aqueous 
phase and film phase, respectively. When the CD is added to the aqueous phase, the drug 
distribution coefficient is: 
 28 
filmfilm
n
i
i
n
i
i
HSS
CDHSHSCDSS
D
][][
][][][][
11








           Equation 2.11 
Dividing Equation (2.11) by Equation (2.10): 
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1                   Equation 2.12 
It is known that the equation for the acid dissociation constant Ka is  
][
]][[



HS
HS
K a                              Equation 2.13 
Inserting Equation (2.8) and Equation (2.13) into Equation (2.12): 
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where K
+
1: j is the binding constant of cationic drug and cyclodextrin. 
If the system is very acidic,  
jK
Ka
H
:1
][


>1 
Equation (2.14) will become 
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If the cationic form of the drug is ignored, Equation (2.14) will become Equation (2.9) again. 
Plotting D/D0 versus [CD], the stoichiometry and the binding constants can be obtained 
from polynomial fitting analyses. In practice, a degree one (linear) fitting should first be 
performed, assuming that only 1:1 complex forms 
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][1 1:1
0
CDK
D
D
         Equation 2.16 
A proper fitting should give a straight line with a y-intercept of unity, and the slope can report 
the value of K1:1. Otherwise linear regression on a quadratic equation should be carried out, 
assuming that both 1:1 and 1:2 complexes form: 
2
2:11:11:1
0
][][1 CDKKCDK
D
D
         Equation 2.17 
Again, a correct fitting should give a y-intercept of unity, and the K1:1 and K1:2 values can be 
obtained from the corresponding coefficients of the polynomial. If the fit is still not satisfactory, 
fitting analyses with higher degrees should be continued. Note that all the coefficients of the 
polynomial should have positive values. In this study, the concentration of CD prepared in the 
aqueous buffer (CCD) is much higher than the drug concentration (CS), hence the drug-CD 
complexation does not significantly change the free CD concentration, and [CD] in those 
equations can be reasonably replaced by CCD.  
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2.3.2 Experimental Results and Discussion 
 
Figure 2.3 Percentage of econazole extracted as a function of time in the presence of six CDs and 
without CD 
 
A kinetic study was first performed to determine the time needed for the phase 
distribution of econazole to reach equilibrium. The results are shown in Figure 2.3. Clearly, 8-9.5 
h is enough for all the distribution experiments to be equilibrated. Careful inspection of the 
curves shows that the equilibration time is shorter when the aqueous phase contains less CD or 
the specific CD has a weaker ability to extract econazole. It also shows that the equilibration 
time for econazole in the absence of CD in the aqueous phase is about 4 h. Also, very low 
percentage of econazole has been extracted into the aqueous phase without CD, which is 
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consistent with the fact econazole has very low aqueous solubility (5 µg/mL at 25 
0
C). Based on 
the kinetic data, all other distribution experiments were allowed to equilibrate for 10 h.  
Instructed by Equation (2.9), the effect of CD concentration on the distribution of 
econazole was then studied. Figure 2.4 gives the profile of econazole equilibrium concentration 
versus CD-content in the aqueous phase for six CDs. Each measurement was repeated for four 
times and the corresponding error bar indicates the standard error of the mean (SEM). The SEM 
values were then used in error propagations to determine the errors of the calculated distribution 
ratios and D/D0 values. Apparently, at higher CD concentration, more econazole is extracted to 
the aqueous phase. For these six CDs, the ability to extract econazole is in the order of DM-β-
CD > α-CD > β-CD > HE-β-CD ≈ HP-β-CD > TM-β-CD, which is in good agreement with the 
previous kinetic study (Figure 2.3) and reported phase-solubility data of several CDs (α-CD > β-
CD > HP-β-CD).[65] Various structures of CDs explain their different binding abilities with 
econazole. Linear regression on Equation (2.17) gives the K1:1 and K1:2 values, as shown in Table 
2.1. The errors are their standard deviations. Some of the fitted curves are shown in Figure 2.5 
and all the coefficients of determination (COD) are listed in Table 2.1. The econazole-CD 
binding constants (K1:1/10
3
 M
-1
) discovered by phase-solubility studies have been reported for α-
CD, HP-β-CD, and β-CD, which are 2.63 ± 0.26, 1.54 ± 0.15, and 1.42 ± 0.13, respectively.[65] 
These values are in the same order of magnitude as the data in Table 2.1, however, because the 
conditions of the experiments differ, the results do not agree quantitatively. Since the pH and 
choice of buffer species have a great effect on the determination of binding constant,[65] the 
literature values measured in pure water should only be used for qualitative purposes. The K1:2 
values are larger than zero, indicating the formation of 1:2 complexes. All K1:2 values are highly 
significant as judged by p values. Probabilities that the values of K1:2 are different from zero 
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based only on chance all < 0.0001 except for the final entry in Table 2.1 (-CD) in which case it 
is < 0.001.  Most studies on imidazole-CD complexation have assumed a 1:1 ratio,[50,66] but 
higher order complexes have also been reported.[67-71] For instance, the stoichiometry of 
econazole/β-CD has been published by several groups to be 1:1,[65,72]  while a study has 
discovered the formation of 2:3 complex.[67]  
 
Figure 2.4 Effect of CD concentrations on econazole equilibrium concentration in the aqueous phase 
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Table 2.1 Binding constants of econazole with six CDs 
D0 Cyclodextrin M.W. (g/mol) K1:1 (10
3
 M
-1
) K1:2 (M
-1
) COD 
(1.20±0.09)10-5 
HE-β-CD ~1480a 3.98 ± 0.13 4.9±0.5 0.9989 
HP-β-CD ~1580a 3.90 ± 0.22 10.0±1.9 0.9976 
DM-β-CD ~1330a 29.3 ± 2.2 57.7±8.7 0.9982 
TM-β-CD 1429.54 0.66 ± 0.04 53.9±3.7 0.9994 
α-CD 972.84 1.78 ± 0.30 256±44 0.9997 
β-CD 1134.98 4.08 ± 0.50 47.6±12.1 0.9956 
 
a
 Randomly substituted. Their average molecular weights are determined by ESI-MS. 
 
 
Figure 2.5 Multivariate linear regression results for fitting D/D0 versus CD concentration. 
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Table 2.2 Binding constants of econazole with HP-β-CD at various temperatures 
Temperature (K) K1:1 (10
3
 M
-1
) COD 
293.15 2.06  0.009 0.9999 
298.15 1.81  0.005 0.9999 
303.15 1.50  0.016 0.9992 
308.15 1.34  0.008 0.9999 
 
The binding behavior of econazole to HP-β-CD has been studied at various temperatures. 
The K values were measured at 293, 298, 303, and 308 K, respectively, which are shown in 
Table 2.2. Since the binding constant is related to the Gibbs free energy (ΔG0) of complexation, 
which comes from enthalpic (ΔH0) and entropic (ΔS0) terms, these thermodynamic terms can 
provide insight into the driving forces for complexation. The thermodynamic parameters for 
inclusion processes were determined from the temperature dependence of the binding constants 
using a van’s Hoff plot (lnK versus 1/T), as seen in Figure 2.6. The plot was linear with a 
correlation coefficient close to unity (R
2
  0.99) within the temperature range considered in the 
present study, indicating that the changes in the heat capacity could be neglected.  
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Figure 2.6 van’t Hoff plot for econazole - HP-β-CD complex 
  
The standard Gibbs free energy change of the binding was calculated using the following 
relations: 
000 ln STHKRTG                      Equation 2.18 
where the ΔH0 and ΔS0 can be deduced from the slope and the intercept of the van’s Hoff plot, 
respectively. In our experiment, ΔH0 was -22.01.4 kJ/mol, ΔS0 was -11.54.5 J/ (mol*K), ΔG0 
(298K) was -18.61.9 kJ/mol. The following conclusions can be made from the data: 
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(1) The K values decrease with rising in temperature, i.e., as the temperature increases, the 
affinity of the cyclodextrin for the drug decreases. This phenomenon is because the formation of 
the complex is exothermic (ΔH0 < 0). 
(2) The negative value of ΔG0 suggests that the complexation is thermodynamically favored. The 
drug binds to CD with a favorable enthalpic term (ΔH0 is less than zero) and an unfavorable 
entropic term (ΔS0 is less than zero). Also, the complex formation is enthalpy driven 
(ΔH0>TΔS0). 
(3) The effect of temperature on drug-CD binding has also been studied by Shehatta etc.[73] 
Their obtained the binding constant of itraconazole with HP-β-CD was (1.17  0.101) 103 M-1 
in 298 K, which was lower than our measurement for econazole- HP-β-CD complex ((1.81  
0.005) 103 M-1), also led to higher standard Gibbs free energy ΔG0 (298K) value (-17.5  0.2 
KJ/mol) than ours (-22.0  1.4 KJ/mol). Itraconazole has a larger size than econazole, which 
contributes to a less favorable affinity of the drug for CD, although their structures are similar. 
Different shapes and sizes results in the difference in the entropic term ΔS0 (- 40.0  4.7 versus -
11.5  4.5 J/ (mol*K)).    
The influence of pH on the apparent binding constant of the econazole-HP-β-CD 
inclusion complex has been studied. As shown in Figure 2.7, a decrease in pH results in a drop in 
the apparent binding constant (K = 2.15103 M-1 at pH 8.5; whereas K = 0.654103 M-1 at pH 5.8) 
indicating that binding constant is larger in the less protonated form for the econazole-HP-β-CD 
complex. Thus, the inclusion process with neutral econazole is more favorable than with 
protonated econazole, which is consistent with literature observations[72]. More quantitatively 
and specifically, we have found that Equation (2.14) can be transformed to 
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where K1:1 is the binding constant of CD with neutral econazole, K
+
1:1 is that with protonated 
econazole, K
App
1:1 is the apparent binding constant of the complex, including CD with both 
neutral and protonated form. After applying nonlinear least-squares curve fitting, as shown in 
Figure 2.7, the K1:1, K
+
1:1, and pKa values of econazole can all be obtained, which are (2.21  
0.06) 103 M-1, (0.47  0.09) 103 M-1, and 6.75  0.08, respectively. The binding constant of 
CD with protonated econazole is smaller than that with neutral form, which confirms our 
previous qualitative conclusion that the inclusion complex between econazole and CD is 
hydrophobically driven. The measured pKa (6.750.08) is statistically indistinguishable from 
the literature value (6.69). 
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Figure 2.7 Effect of pH on the apparent binding constant of the econazole-HP-β-CD complex 
 
Compared to the phase-solubility method, which can require days for the dissolving of 
the drug to be saturated, this new technique is faster. Moreover, the drug amounts used in 
solubility experiments are much greater than in this method. For instance, the highest econazole 
concentration in a phase-solubility study is ~30 mM,[65] but in the phase-distribution 
experiment, CS is less than 0.1 mM. In addition, the volume of the CD solution used in a 
solubility study is typically 10 mL, which is 40 times more than in this distribution experiment. 
These two factors have led to a 12000 fold decrease in material requirements. The equilibration 
time is shorter in these phase-distribution studies probably because it does not involve the 
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equilibrium between solid and dissolved drug. For other phase-distribution methods, which study 
the drug distribution between an organic solvent and an aqueous phase, the solvent-CD 
complexation may lead to misinterpretation. In addition, entrainment and emulsion can be severe 
problems for very hydrophobic compounds,[40] and the handling of small volumes of organic 
solvent may be difficult.[27]  
In phase-solubility studies, several factors influence the accuracy of the final result. One 
such factor is the accurate and precise determination of the intrinsic solubility (S0). Similarly for 
this approach, the variance of D0 may lead to misinterpretation of n and K1:i as well. Since the 
drug concentration is usually low (~0.01-0.1 µM) when determining D0, some error is inevitable. 
Ways to decrease the measurement error of D0 have been discussed elsewhere.[27] The most 
important aspect in getting an accurate value for D0 is the sensitivity and selectivity of the 
analytical method used to measure the concentrations of the solute. As far as precision is 
concerned, the 96-well plate approach is beneficial, as it is easy to do repeat measurements. 
Other potential errors may arise from the distribution process itself. The drug may adsorb to the 
plate surface. We have determined that this does not occur for a series of compounds ranging in 
their octanol-water partition coefficients over a logarithmic range of 0.5 to 3.2[48]. Another 
potential source of error is that DOS may associate with CDs, and thus compete with the drug 
and lead to inaccurate binding constants. In the experiments described herein, the CDs are in 
great excess over the drug, so competition is minimized. Nonetheless, we have determined that 
there is no detectable DOS extracted into aqueous solution containing 10 % (w/v) HP- -CD. 
All of the experiments except the kinetic study were carried out at equilibrium. It is worth 
noting that, in our experience, solute drug distribution at early times before equilibrium is 
correlated with the equilibrium concentration. As Figure 2.3 shows, after only one hour of 
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equilibration it is already obvious that 10% DM--CD is best solubilizing agent for econazole. 
Although we have not investigated this thoroughly, it seems clear that screening to determine the 
rank order of the effectiveness of a series of potential solubilizers could be carried out much 
more rapidly than the equilibrium studies that we have discussed herein.   
2.4  CONCLUSIONS 
We have successfully developed a new method to measure the binding constants of drug-
CD complexes in the aqueous phase using high-throughput technologies. This method measures 
the distribution behavior of a drug between a polymer phase and an aqueous phase in 96-well 
microplates. With four repeats, distribution ratios of econazole with respect to six CD-containing 
buffers at four different concentrations can be determined simultaneously. Multivariate linear 
regression has been established to give the binding constants of econazole to the six CDs 
respectively. Both 1:1 and 1:2 complexes are found and the calculated K1:1 can be correlated to 
some literature data from phase-solubility studies. The thermodynamic parameters of the 
complexation process have been calculated, indicating that the complex formation is exothermic 
and enthalpy driven (ΔH0>TΔS0). The binding constants of econazole to HP-β-CD have 
been also studied at various pH conditions. An acidic environment weakens the binding between 
econazole with HP-β-CD due to more favorable inclusion process with neutral econazole than 
with protonated form. Nonlinear fitting of the apparent binding constants with pH leads to 
binding constants of both the neutral and protonated form and pKa of econazole. Compared to the 
phase-solubility method, our protocol is much faster. Moreover, the material requirement 
decreases four orders of magnitude. This method has great flexibility as well, for instance, 
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‘multiplex’ approaches are possible due to the much lower concentration of the drug relevant to 
the CD concentration. In addition, this method is possible to be fully automated.  
 42 
3.0  LIPOPHILICITY SCREENING OF NOVEL DRUG-LIKE COMPOUNDS AND 
COMPARISION TO CLOGP 
This chapter has been published in J. Chromatogr. A, 2012, 1258, 161. Reproduced with 
permission from J. Chromatogr. A. Copyright (2012) Elsevier.  
3.1 INTRODUCTION 
Acid dissociation constants (pKas) and the logarithmic value of the 1-octanol/water 
partition coefficient (log Pow) are important parameters in environmental, medical, toxicological 
and pharmaceutical studies of novel organic molecules. Sixty-three percent of the molecules 
listed in the 1999 World Drug Index are ionizable between pH 2 and pH 12[38]. Various ionized 
forms of a compound may differ in physical, chemical, and biological properties, so it is 
important to predict which ionic form of the molecule is present at the site of action. The 
partition coefficient is often used in combination with the pKa value to predict the distribution of 
a compound in a biological or ecological system. This knowledge can be valuable in the 
estimation of drug absorption, distribution, metabolism, and excretion (ADME), or for the 
estimation of the distribution of a solute in an ecological system.  
Numerous methods exist to measure or estimate the pKa and log Pow values. The shake-
flask method and RP-HPLC method are the main experimental methods to determine partition 
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coefficients. The shake-flask procedure is a standard method to determine octanol/water partition 
coefficients in the range of -2 to 4[46,74]. This method is the most reliable and accurate one, 
however, it is tedious, time consuming, and requires large amounts of pure material. In addition, 
octanol/water emulsions can be severe problems, especially for hydrophobic compounds, 
limiting the upper measurable log Pow value to 4[40]. Recently, a micro-volume flow extraction 
system consuming less than 1 mL of octanol and aqueous sample has been developed[75]. To 
increase sample throughput, the traditional shake-flask method has been automated and scaled 
down using 96-well plate technology and a robotic liquid handler[76]. However, the emulsion 
problem still exists for scaled down shake flask method, especially for hydrophobic compounds. 
The RPLC method is an indirect but popular way to measure log Pow values in the range 
of 0-6[77]. This method is rapid and reproducible for sets of similar compounds, although 
impurities may make the interpretation of the results difficult due to uncertainty in peak 
assignments. However, it is not applicable to strong acids and bases, metal complexes, 
substances that react with the eluent, or surface-active agents[40].  One further disadvantage with 
this method is that the reference compounds should be preferably similar to those being studied 
and difficulties arise if suitable standards are unavailable.   
There are some theoretical approaches to predict lipophilicity. Most of them add up the 
log Pow contribution from each fragment and then apply structure-based correction factors[46].  
There are at least 20 software packages available at present, which provide convenient and fast 
prediction of lipophilicity for novel compounds. However, studies show calculations are not 
reliable for log Pow and pKa of zwitterionic, tautomeric and charged compounds as well as for 
strong hydrogen-bonding compounds[78]. It was reported by investigators at Wyeth 
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Research[79] that the average difference between the calculated and measured log Pow values for 
70 commercial drugs is about 1.05 log units.  
Recently, our group has developed a high-throughput phase-distribution method based on 
partition of the analyte between a polymer phase and an aqueous phase in a 96-well format. The 
polymer phase is composed of poly (vinyl chloride) (PVC) and dioctyl sebacate (DOS) at the 
ratio of 1:2 (w/w). Studies in our group[48] on the correlation of polymer/water partition 
coefficient log Ppw and standard 1-octanol/water partition coefficient (log Pow) have shown a 
good linear relationship with the slope of 0.933 and the intercept close to zero, indicating that 
DOS plasticized PVC had lipophilicity similar to octanol. Therefore, our polymer/water partition 
coefficient can be used to predict lipophilicity. This method has been applied to screen chiral 
selectors[64] and to measure binding constants of drug-cyclodextrins inclusion complexes[80]. 
In this paper, we have first applied our method to determine pKa and lipophilicity of a 
drug-like compound 2H-1, 2, 6-thiadiazine, 3-methyl-5-phenyl-, 1, 1-dioxide (Figure 3.1). 
Compounds with the 2H-1, 2, 6-thiadiazine-1, 1-dioxide substructure are prominently featured in 
patent and medicinal chemistry as hepatitis C virus (HCV) polymerase inhibitors[81], non-
nucleoside HIV-1 reverse transcriptase inhibitors[82], analgesics[83], and smooth muscle 
relaxants[84]. We have further used this high-throughput method to screen lipophilicity of a 
library of twenty-four novel drug-like compounds. Their Log Dpw values (at pH 4.0, 7.0, 10.0) 
can be measured with good reproducibility in a high-throughput and automated format. We have 
found that there is a relatively poor correlation between those experimental values and calculated 
values with various methods. 
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Figure 3.1 Chemical structure of 2H-1, 2, 6-thiadiazine, 3-methyl-5-phenyl-, 1, 1-dioxide. 
3.2  EXPERIMENTAL 
3.2.1 Materials 
Acetonitrile (HPLC grade), tetrahydrofuran (THF) (HPLC grade) and dimethyl sulfoxide 
(DMSO) (anhydrous, 99.9%) were purchased from Aldrich (Milwaukee, WI). PVC (high 
molecular weight) and dioctyl sebacate (DOS) were purchased from Fluka (Ronkonkoma, NY). 
HPLC grade trisodium phosphate, phosphoric acid, trifluoroacetic acid (TFA) were also 
purchased from Fluka (Ronkonkoma, NY). Water used in all the experiments was purified with a 
Milli-Q Synthesis A10 system (Millipore, Bedford, MA). Costar polypropylene 96-well 
microplates (flat bottom, 330-µL well volume) were purchased form Fisher Scientific Co. 
(Pittsburgh, PA). Storage plate cap strips were purchased from Thermo Scientific Co. (Waltham, 
MA). 2H-1, 2, 6-thiadiazine, 3-methyl-5-phenyl-, 1, 1-dioxide and a library of twenty-four drug-
like compounds were synthesized in the University of Pittsburgh Center for Chemical 
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Methodologies and library Development (UPCMLD) (Pittsburgh, PA). See Table 3.1 and 3.2 for 
structures and PubChem SID numbers. 
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Table 3.1 Experimental Design of 24 compounds in a 96-well microplate 
 Wells 1-4 Wells 5-8 Wells 9-12 
A 
  
 
B 
 
 
 
C 
   
D 
 
 
 
E 
 
 
 
F 
  
 
G 
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H 
 
 
 
 
Table 3.2 PubChem SID of 24 compounds in a 96-well microplate 
 Wells 1-4 Wells 5-8 Wells 9-12 
A
A 26696971 26681202 17390303 
B
B 26696976 26683722 26696997 
C
C 26696951 26683740 26681305 
D
D 26696995 8142836 26681407 
E
E 26696950 8142904 26681268 
F
F 87341695 26696959 26681269 
G
G 26696948 8143072 26681280 
H
H 26697001 8143105 8143071 
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3.2.2 Equipment 
An UltraSpense 2000 microplate dispenser (KD Scientific, Holliston, MA) was used to 
prepare polymer films in 96-well plates. A Deep Well Maximizer (or BioShaker) (Model: 
M·BR-022 UP, made by Taitec, Japan, and distributed by Bionexus, Inc., Oakland, CA) was 
used to speed up the solute distribution kinetics and control temperature. An HT-4X evaporator 
(Genevac inc., Gardiner, NY) was used to evaporate organic solvents. An X-LC (Jasco, Inc.) 
UHPLC system was used to determine the solute concentration with a UHPLC C18 column (1.0 
× 50 mm, particle size: 1.7 µm, Waters, Milford, MA). UV absorbances of solutes were acquired 
with a SpectraMax M2 microplate reader (Molecular Devices, Sunnyvale, CA) in UV-
transparent microplates. 
3.2.3 Buffer Preparation 
The phosphate-citrate buffer solutions (20 mM, pH 2.7, 2.8, 3.2, 3.9, 4.0, 5.1, 6.1, 7.0, 7.2) 
were made by mixing appropriate amounts of 20 mM sodium phosphate dibasic solution and 10 
mM citric acid solution. The phosphate buffer solutions (20 mM, pH 1.9, 2.5, 9.2, 10.0) were 
made by mixing appropriate amounts of 20 mM trisodium phosphate solution and 20 mM 
phosphoric acid solutions. The trifluoroacetic acid (TFA) buffer solutions (pH 0.9, 1.1) were 
made by preparing 0.2%, 0.1% TFA in water (v/v) respectively.   
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3.2.4 Determination of log Ppw and pKa of a Solute 
Figure 3.2 gives the sequence of operations for Ppw and pKa determination of a solute. 
The plasticized PVC films were prepared in polypropylene 96-well microplates. Aliquots of the 
solute in the aqueous buffers (200 L) with different pH values were then manually dispensed 
over the films with a multichannel pipet. The wells in each plate were covered by storage plate 
caps and the plate was incubated in a shaker (500 rpm, 25 ºC). In order to determine the 
equilibration time, a kinetic study was first performed. The concentration of solute remaining in 
the aqueous phase was measured as a function of time. All of the other data generated were from 
systems at equilibrium. To determine the drug concentration, the supernatant from each well was 
transferred to another plate. Concentrations can be determined either by UHPLC or by measuring 
the absorbance in a UV plate reader. The distribution coefficient at a specific pH could be 
calculated as 
                                           
 
E
ESpH
pw
C
CC
D

                                          Equation 3.1 
Here Dpw
pH 
is the distribution coefficient of the solute in the polymer phase over the aqueous 
phase at a specific pH value. CS is the initial solute aqueous concentration, CE is the solute’s 
aqueous concentration at equilibrium after the extraction, and Φ is the phase ratio (aqueous over 
polymer). 
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Figure 3.2 Schematic of the preparation and use of polymer films in 96-well plates for Log Dpw 
determination. 
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3.2.5 UHPLC Method to Determine Concentrations of the Thiadiazine 
A Waters UHPLC C18 column was used for this method. The mobile phase was 
acetonitrile-ammonium acetate buffer (pH 4.92; 10 mM) (20:80, v/v), with a flow rate of 0.1 
mL/min. The back-pressure was approximately 4300 psi. The injection volume was 2 µL. 
Detection was by UV absorbance at 343 nm, at which the solute peak had best signal-to-noise 
ratio. Peak area was used for the calibration and determination of sample concentration. The time 
per analysis was ~1.3 min. 
3.2.6 UV Plate Reader Method to Determine Concentrations of the Thiadiazine 
UV absorbances of the solute at 343 nm were used for calibration and determination of 
solute concentrations. They were acquired with a microplate reader in UV-transparent 96-well 
plates. Absorbances of the buffers were measured as the background and subtracted to get the 
absorbances of the solute.   
3.2.7 Lipophilicity Screening of the Library 
Ten nmol of 24 compounds in 20 µL DMSO were placed in a 96-well microplate 
according to the experimental design shown in Table 3.1. The PubChem SID numbers of those 
compounds are shown in Table 3.2. According to the experimental design shown in Figure 3.2, a 
THF solution of plasticizer and PVC was then dispensed into the plate, which was gently shaken 
for a few minutes to let the compound and the polymer dissolve in THF/DMSO mixed solvent. 
An evaporator was then used to evaporate THF and DMSO, leaving homogeneous polymer films 
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with dissolved solutes formed at the bottom of the wells. Aliquots of the aqueous buffer solutions 
(pH 4.0, 7.0, 10.0) were then dispensed on top of the polymer films in the plate. The plate was 
covered and incubated in a shaker (500 rpm, 25 ºC) for 4 hours. To determine the solute 
concentration, the supernatant from each well was transferred to another UV-transparent plate by 
a multichannel pipet and put in the plate reader for UV determination at 250 nm, at which sample 
peaks showed the best signal-to-noise ratios. If all of the solute was extracted into the 100 µL of 
aqueous phase, the solute concentration in the aqueous buffer would be 100 µM. 
3.3  RESULTS AND DISCUSSION 
3.3.1 Theories to Determine Partition Coefficient and pKa of a Solute simultaneously 
2H-1, 2, 6-thiadiazine, 3-methyl-5-phenyl-, 1, 1-dioxide is a weakly acidic amide due to 
its sulfonamide group. It will be largely ionized in an environment having pH larger than its pKa. 
In practice not only neutral molecules but also ion pairs may partition. The distribution of the 
neutral and the ionized form between the polymer film phase and the aqueous phase is 
determined by the distribution coefficient Dpw: 
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                                                      Equation 3.2 
Where [HS] and [HS] film are the drug concentrations in the aqueous phase and film phase, 
respectively; [S
-
] and [S
-
] film are the concentrations of the ionized drug and its ion pair in the 
aqueous phase and film phase. The partition coefficient for the neutral drug is defined as: 
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The partition coefficient for the anionic drug and its ion pair is defined as: 
                              
][
][


 
S
S
P
film
pw                                                                     Equation 3.4 
It is known that the equilibrium equation for acid dissociation constant Ka is  
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Inserting Equation (3.3), (3.4), and (3.5) into Equation (3.2): 
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 Equation 3.6 
By plotting Dpw versus pH, the Ppw, Ppw
-
 and pKa values of the solute can be obtained by 
applying a nonlinear least-squares curve fitting according to Equation (3.6). 
3.3.2 Determination of log Ppw and pKa of a solute in a 96-well format 
A kinetic study was first performed to determine the time needed for the phase 
distribution of the solute to reach equilibrium. The results show that 2 h were enough for the 
distribution experiments to reach equilibrium. Based on the kinetic data, all other distribution 
experiments were performed for 4 h. 
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Figure 3.3 Distribution coefficients of 2H-1, 2, 6-thiadiazine, 3-methyl-5-phenyl-, 1, 1-dioxide at 
various pH values analyzed by UHPLC. 
 56 
 
Figure 3.4 Distribution coefficients of 2H-1, 2, 6-thiadiazine, 3-methyl-5-phenyl-, 1, 1-dioxide at 
various pH values determined by plate reader. 
 
Distribution coefficients of the compound, 2H-1, 2, 6-thiadiazine, 3-methyl-5-phenyl-, 1, 
1-dioxide were determined at various pH values, analyzed by both UHPLC and UV plate reader. 
The results obtained by UHPLC and plate reader are shown in Figure 3.3 and 3.4 respectively. 
Each measurement was repeated twice and the corresponding error bars indicate the standard 
error of the mean (SEM). The SEM values were then used in error propagations to determine the 
errors of the calculated distribution coefficients. It is shown that distribution coefficient of the 
compound decreases with increasing pH of the buffer, indicating more ionic form existing in the 
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higher pH range, which is consistent with the fact 2H-1, 2, 6-thiadiazine, 3-methyl-5-phenyl-, 1, 
1-dioxide is an acidic amide. Applying nonlinear least-squares curve fitting based on Equation 
(3.6), the Ppw, Ppw
-
 and pKa values of the solute were obtained. The pKa values of the solute are 
2.94  0.10 and 2.52  0.17, determined by HPLC and plate reader measurements of the 
equilibrium concentration of the solute in the aqueous phase respectively. The log Ppw values are 
1.04  0.02 and 1.10  0.03 respectively. Both of the Ppw
-
 values are statistically zero (p > 0.05), 
indicating most of the ionized solute stays in the aqueous phase rather than the polymer film 
phase.   
To our knowledge, there have been no reported experimental log P and pKa values for 
2H-1, 2, 6-thiadiazine, 3-methyl-5-phenyl-, 1, 1-dioxide. Compared to the calculated log Pow 
(1.10  0.75) using ACD software (Advanced Chemistry Development inc., Toronto, Canada), 
our results are consistent and showed better precision. The calculated pKa value from ACD 
software and ADMET Predictor
TM
 software (Simulations Plus inc., Lancaster, CA) are 5.13 and 
0.25 respectively, which are quite different from each other, while our results are in the middle. 
2H-1, 2, 6-thiadiazine, 3-methyl-5-phenyl-, 1, 1-dioxide is a tautomeric and ionizable compound 
with both acidic and basic centers. It is known that predictions are not particularly good for 
partition coefficients and pKa values of zwitterionic, tautomeric and charged compounds[78].  
The UHPLC method gives better sensitivity than the optical absorbance measurements[48]. 
Unlike the plate reader method, it does not suffer from the potential for interfering compounds 
biasing the result. The higher sensitivity translates into the method’s capability to measure a 
wider dynamic range of log Ppw values in comparison to the optical absorbance approach [10]. 
On the other hand, compared to the plate reader, the UHPLC measurement generates lower 
throughput due to method development time. Thus both approaches have strengths. For detailed 
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analysis of a single compound, the UHPLC method may be better, but for screening large 
numbers of dissimilar compounds, the optical absorbance method is preferred unless the molar 
absorptivities of the solutes are too low. 
3.3.3 Optical Absorbance-based Lipophilicity Screening of a Library of Drug-like 
Compounds 
 
Figure 3.5 Correlation of distribution coefficients between different runs. 
  
The experimental log D results (pH 4.0, pH 7.0, and pH 10.0) of all of these compounds 
have been successfully obtained. As shown in Figure 3.5, good linearity was found for a plot of 
log D for each compound in separate runs with a correlation coefficient of 0.97. A slope of 1.00 
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± 0.05 and an intercept of -0.04 ± 0.10 (p>0.05, statistically zero) was found, showing good 
reproducibility of our method. The experimental log DpH7.0 results are located in the range of 0.68 
to 3.12. According to Lipinski’s rule of five[85,86], drug-like molecules should have log D 
values less than five for reasonable absorption and permeation. These compounds have 
appropriate log D values to be considered as drug-like compounds. Errors in the quantitative 
determination of solute concentrations contributed to the limits for the applicable log D range of 
our method. For example, if the log D value is equal to -1 at the phase ratio equal to 16, the final 
concentration after the extraction would be 99.4% of the initial concentration calculated from 
Equation (3.1), meaning the error could not be higher than 0.3%, which is not easy to achieve 
with optical absorbance. Therefore, the measurable log D range of our method is three units at 
one fixed phase ratio. Of course, it is easy to alter the phase ratio by changing the volume of the 
aqueous phase and the polymer phase. For example, this method successfully measured the 
lipophilicity of the hydrophobic drug econazole (log P = 4.83)[48]. This is a challenge for the 
shake-flask method. 
Compared to other experimental methods, this method shows several advantages. The 
technique is faster, more automated, and compatible with microplates unlike the standard shake-
flask method. This method also demonstrates capability of determining log D for charged 
compounds which is a challenge for the RPLC method. 
Our experimental results and calculated log D values by MarvinView software 
(ChemAxon Ltd., Budapest, Hungary) and the correlation are represented in Table 3.3 and 
Figure 3.6 respectively. There were rather poor correlations between measured (y) and calculated 
(x) log D values with y=1.86 +0.08*x (r=0.16), y=1.64+0.19*x (r=0.50), y=1.79+0.11*x 
(r=0.37), for pH 4.0, 7.0, and 10.0 respectively. The average difference between the calculated 
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and measured values is 1.04 log units, which is similar to the reported difference (1.05 log units) 
for 70 commercial drugs[79]. Computational approaches will always be approximate because 
new compounds may contain substructures that are not covered by the software. Therefore, an 
accurate contribution of each substructure of the new compounds may not exist. Moreover, it is 
known that theoretical predictions are not reliable for distribution coefficients and pKa values of 
zwitterionic, tautomeric and charged compounds[78], like most of the compounds in this library. 
 
Table 3.3 Experimental and calculated log D results for 24 compounds at pH 4.0, 7.0, 10.0 
 pH 4.0 pH 7.0 pH 10.0 
Wells Measured Calculated Measured Calculated Measured Calculated 
A 1-4 1.87 1.82 1.62 0.28 1.80 -0.55 
B 1-4 3.04 3.34 2.79 3.34 2.75 1.10 
C 1-4 2.47 3.38 0.93 0.87 0.99 -0.21 
D 1-4 2.21 2.39 2.22 2.39 2.21 2.39 
E 1-4 1.40 1.55 1.78 -0.16 1.88 -1.47 
F 1-4 2.00 2.56 2.01 2.72 1.96 2.72 
G 1-4 2.54 2.91 2.57 2.91 2.58 2.91 
H 1-4 2.40 2.55 2.12 2.55 2.26 2.55 
A 5-8 2.22 3.00 2.16 3.00 1.90 3.00 
B 5-8 1.60 2.89 1.94 2.89 1.75 2.89 
C 5-8 2.45 2.78 2.22 2.80 2.08 2.80 
D 5-8 1.38 1.78 1.37 1.83 1.40 1.83 
E 5-8 2.18 -0.84 2.14 1.82 2.20 2.09 
F 5-8 1.75 2.03 1.94 2.41 1.89 2.41 
G 5-8 1.69 2.72 1.19 0.01 1.16 -0.41 
H 5-8 1.94 1.33 1.92 -1.40 1.76 -1.91 
 61 
A 9-12 3.18 2.41 3.12 2.41 3.02 2.41 
B  9-12 1.76 1.29 2.01 0.75 2.01 -1.98 
C  9-12 1.99 1.16 2.02 1.22 1.89 1.22 
D  9-12 2.06 2.97 2.10 2.97 2.01 2.97 
E  9-12 2.00 -1.15 2.05 -1.15 2.09 -1.15 
F  9-12 2.14 0.62 2.09 0.62 2.08 0.62 
G 9-12 1.59 1.59 1.45 1.59 1.49 1.59 
H  9-12 0.56 2.72 0.68 0.01 0.77 -0.41 
 
 
 
Figure 3.6 Correlation of distribution coefficients between our experimental values and calculated 
values.  
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We then compared experimental log P values and clogP for only the neutral compounds 
in the library by four different software packages, ACD, Marvin, QikProp (Schrodinger, 
Portland, OR), and Sybyl (Tripos Inc., St. Louis, MO). As summarized in Table 3.4, a total 
average log P difference of 0.58 log units are shown for neutral compounds, smaller than that for 
ionizable compounds. Better correlations between measured (y) and calculated (x) log P values 
were shown with y=0.91+0.52*x (r=0.91), y=1.31+0.31*x (r=0.43), y=0.96+0.46*x (r=0.45), 
y=0.92+0.47*x (r=0.82) for ACD, QikProp, Marvin, and Sybyl respectively. We note, however, 
that even for neutral compounds the range of clogP values yielded by the different programs is 
often significant. 
Table 3.4 Experimental and calculated log P results for 10 neutral compounds in the library. 
Wells Experimental 
log P 
ACD QikProp Marvin Sybyl RSD% of 
calculated 
log P 
Average 
Difference 
D 1-4 2.21 2.74 3.25 2.39 2.76 13% 0.57 
G 1-4 2.56 3.20 3.59 2.91 3.25 9% 0.67 
H 1-4 2.26 2.53 3.03 2.55 2.83 9% 0.47 
A 5-8 2.09 2.35 2.72 3.00 2.11 15% 0.45 
B 5-8 1.76 2.24 2.75 2.89 2.83 11% 0.91 
C 5-8 2.25 1.99 2.77 2.80 3.20 19% 0.57 
D 5-8 1.38 1.58 2.33 1.81 1.92 16% 0.53 
A 9-12 3.11 3.96 2.26 2.41 3.84 29% 0.78 
D  9-12 2.06 2.05 2.20 2.97 1.97 20% 0.29 
G 9-12 1.51 0.73 1.09 1.59 0.77 38% 0.51 
 
Our choice of buffer components was made based on the range of pH values and the 
compatibility with the analytical methods used. We also wanted to minimize the number of 
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buffer components use across the total range of pH values. Ultimately, we chose phosphate and 
phosphate/citrate which are adequate for the entire pH range investigated except near pH 10. We 
determined that the poor buffer capacity of phosphate at pH 10 was not a limitation. From Table 
3.3, the lowest clog DpH10 is about -2. Using Eqn.1, the aqueous concentration for this solute 
would be 100 µM at equilibrium (phase ratio = 20). The phosphate buffer concentration is 20 
mM. So the solute concentration is at most 0.5% of the buffer concentration. The pKa values of 
phosphoric acid are 2.1, 7.2, and 12.2. At pH 10, [HPO4
2-
]/ [PO4
3-
] =158. From the structures 
shown in Table 3.1, most of our solutes in the library are amines. If the solute has the same basic 
strength as NaOH, which is the worst case, 0.5% of the acidic ion will be neutralized, pH=12.2-
log (157.2/1.8)=10.26. The small change of pH will not influence the measured distribution 
coefficient unless the pKa of the solute is around 10. In that case, only about half of the solute 
can neutralize the acidic ion in the buffer (0.25%), pH=12.2-log (157.6/1.4)=10.15. In 
conclusion, despite the phosphate buffer’s low strength at pH 10.0 distribution coefficients will 
be measured accurately in our experiment because of the solute and buffer concentrations used.  
3.4 CONCLUSIONS 
We have successfully developed a phase-distribution method to measure simultaneously 
pKa and lipophilicity of drug-like compounds using well-plate technologies. This method has 
been applied successfully to measure pKa and log Ppw values of a drug-like compound, 2H-1, 2, 
6-thiadiazine, 3-methyl-5-phenyl-, 1, 1-dioxide. Moreover, the distribution coefficients of a 
library of novel drug-like compounds were determined by this approach. This method is fast, 
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requires only a small amount of material, has great flexibility, and has the potential to be fully 
automated; thus showing great potential in the pharmaceutical and environmental fields. 
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4.0   FLUOROUS RECEPTOR-FACILITATED SOLID PHASE MICROEXTRACTION 
This chapter has been published in J. Chromatogr. A (DOI:10.1016/j.chroma.2014.07.060). 
Reproduced with permission from J. Chromatogr. A. Copyright (2014) Elsevier.  
4.1 INTRODUCTION 
Sample preparation is an essential step in the analysis process. Solvent-free extraction is 
considered to be a green analytical method as it prevents hazards to the environment and human 
health. Solid phase microextraction (SPME) is a widely accepted solvent-free extraction 
technique that usually uses a polymer sorbent as the extraction phase. Various configurations of 
SPME have been considered to date, including coated fibers and vessels[3].  
The selection of sorbent polymer material is the most important step controlling the 
selectivity of the extraction[8]. One of the recent trends in SPME is to study new coatings with 
higher extraction efficiency and selectivity[9]. Recently developed coatings for selective 
extraction include molecularly imprinted polymers (MIP)[10-17], ionic liquids[19-23], metal 
complexes[24], and carbon nanotubes[25,26]. We showed some time ago that a molecular 
receptor for barbiturates embedded in the extraction phase enhances the selectivity of SPME for 
barbiturates that bind well to the receptor[87]. Such receptors are potentially very powerful tools 
for selective extractions by taking advantage of noncovalent bonding between a receptor and an 
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analyte. However, while receptors can improve selectivity by augmenting the distribution 
coefficient of the selected analytes, the matrix in which the receptor resides plays a role as well. 
Ideally, the matrix would decrease the distribution coefficient for uninteresting analytes while 
the receptor increases the distribution coefficient of interesting analytes. This notion guided us to 
fluorous solvents and materials as potential matrices for SPME. 
Fluorous solvents are the least polar practical solvents known[88]. Fluorous liquids are 
virtually immiscible with both aqueous and most organic phases. Due to their extreme nonpolar 
character, noncovalent associations including hydrogen bonding tend to be enhanced in fluorous 
media[89]. Molecular recognition has been combined with fluorous matrices to improve 
extraction selectivity by reducing the interfering species extracted. Palomo et al. reported that the 
fluorous solubility of fluorinated N, N’-dialkylureas could be enhanced by embedding 
perfluoroalkanoic acids in perfluorohexanes (FC-72) due to formation of hydrogen bonded 
complexes[90]. O’Neal and coworkers also reported that a carboxylic acid terminated poly-
hexafluoropropylene oxide, Krytox 157 FSH (1), significantly enhances the extraction of 
pyridines from chloroform into FC-72 by forming a hydrogen bond between the pyridine ring 
and the carboxylic acid group[91].  
Teflon AF 2400 (2) is a chemically inert and thermally stable amorphous fluorinated 
polymer. It is a copolymer of tetrafluoroethylene (13%) and 2, 2-bistrifluoromethyl-4, 5-
difluoro-1, 3-dioxole (87%)[92]. Homogeneous thin films of Teflon AF 2400 are easily prepared 
through solvent casting[93]. They are transparent through a wide UV-Vis and IR range[94], 
making them ideal to study noncovalent associations. Teflon AF 2400 has a high fractional free 
volume (FFV) probably due to its rigid structure of the dioxolane ring and the weak van der 
Waals interactions between fluorous polymeric chains[18]. Krytox 157 FSH is thermally stable 
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and can be easily incorporated into Teflon AF 2400 films. Krytox 157 FSH and Teflon AF 2400 
were found to be miscible in any proportion[95].  
We are interested in developing receptor-doped fluorous films for solid phase 
microextraction. The hydrophobic and lipophobic properties of the fluorous films will reduce the 
polymer-water distribution coefficient of all solutes except the ones that can form noncovalent 
interaction with the fluorous receptor, making extractions selective. 
We recently reported a 96-well parallel design to measure distribution coefficients of 
novel drug-like compounds between a plasticized polyvinyl chloride (PVC) film and an aqueous 
phase[96]. This parallel design is fast and only requires small amounts of sample. In this work, 
we have applied this parallel approach to create a 96-well vessel SPME to study distribution 
between receptor-doped fluorous polymer phase and an aqueous phase. Based on previous 
results on hydrogen bonding of pyridine and pyridine derivatives with carboxylic acids in the 
fluorous liquids[91], we chose to study the distribution behavior of quinoline (3), an 
environmental contaminant and a probable human carcinogen[97], between a fluorous polymer 
phase composed of Krytox 157FSH doped Teflon AF 2400 and an aqueous phase.  
We found that the addition of a fluorous carboxylic acid to the film increased the 
polymer-water distribution coefficients of the nitrogen heterocycle. We studied the effects of 
receptor concentration and solute concentration on the distribution coefficients based 96-well 
vessel SPME. We then coated this receptor doped fluorous polymer on a stainless steel fiber for 
SPME. Compared to a commonly used SPME fiber made of polydimethylsiloxane (PDMS), 
Krytox 157-FSH doped Teflon AF 2400 showed a preference for the nitrogen heterocyclic 
compound over a non-heterocyclic control, phenol. To our knowledge, this is the first reported 
receptor-doped fluorous SPME. 
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Figure 4.1 Structure of Ktytox 157 FSH (1), Teflon AF 2400 (2), quinoline (3) 
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4.2 EXPERIMENTAL 
4.2.1 Chemicals and Solutions 
Quinoline and tris (hydroxymethyl) aminomethane hydrochloride buffer substance (Tris 
buffer) were obtained from Aldrich (Milwaukee, WI). Phenol and nitric acid were bought from 
EM Science (Cherry Hill, NJ). Krytox 157FSH was purchased from Miller-Stephenson Chemical 
Co., Inc. (Danbury, CT) with a number averaged molecular weight of 5150 g/mol based on an 
average of 29 polymer repeat units determined by 
19
F-NMR[98]. Teflon
®
 AF 2400 was 
purchased from DuPont (Wilmington, DE). Fluorinert FC-72 (a mixture of perfluorohexanes) 
was purchased from 3M (St. Paul, MN). Aqueous tris(hydroxymethyl)aminomethane buffer (tris 
buffer hereafter) solutions (50.0 mM, pH = 8.0) were prepared by dissolving tris buffer pH 8.0 
substance (Sigma Aldrich, Milwaukee, WI) in purified water (Milli-Q water) from a Millipore 
Synthesis A10 system (Millipore, Billerica, MA). Quinoline and phenol solutions with a variety 
of concentrations were prepared in this tris buffer.  
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4.2.2 96-well Vessel SPME: Preparation and Extraction  
  
Figure 4.2 General procedure for 96-well vessel SPME. 
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As outlined in Figure 4.2, receptor-doped fluorous polymer films were prepared in Costar 
polypropylene 96-well microplates (flat-bottom, 330 µL well volume). Both Teflon AF 2400 and 
Krytox 157FSH were initially prepared in FC-72 at a concentration of 10 mg/mL. These 
solutions were combined to give 200 L of a solution that would yield films with ratios of 0.0%. 
12.5%, 25%, 37.5%, 50%, 75%, 100% (w/w) Krytox. Final film weights are therefore 2.0 mg. 
After the polymer films were formed, 200 μL aliquots of the aqueous solute-containing films 
solutions were added to undivided wells. Plates were sealed by a cover and equilibrated in a 
shaker (BioShaker MBR-022U, made by Taitec and distributed by Bionexux Inc., Oakland, CA) 
at 500 r/min at 25.0 °C. In order to determine the necessary equilibration time, the percentage of 
quinoline extracted into the polymer phase was measured as a function of time. Other than in this 
experiment, all data were generated at equilibrium. After equilibrium was achieved, 100 μL 
aliquots from each well were transferred into a UV-transparent microplate by a multichannel 
pipette. To determine the solute concentrations, UV absorbance was measured by a SpectraMax 
M2 microplate reader (Molecular Devices, Sunnyvale, CA). The distribution coefficient could be 
calculated as 
                                                             
 
E
ES
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C
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
                Equation 4.1 
Here Dpw
 
is the distribution coefficient of the solute in the polymer phase over the aqueous phase. 
CS is the initial solute aqueous concentration, CE is solute aqueous concentration at equilibrium 
after the extraction, and Φ is the volume phase ratio (aqueous over polymer). 
The volume of each film was estimated as 
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Here Vsolution is the volume of the FC-72 solution used in each well and dfilm is the density of the 
film, which is estimated to be 2 g/mL. In this work, 200 μL of the FC-72 solution was dispensed 
in each well, so the volume of each film was about 1 μL. The phase ratio was 200 as 200 μL of 
the aqueous solution was used. 
4.2.3 Coated Fiber SPME-GC: Fiber Preparation, Extractions, and Desorption on GC 
The stainless steel wires were first soaked in 4 M HNO3 to clean and passivate the steel. 
They were then rinsed with Milli-Q water and dried in the air. The exposed stainless steel fibers 
were then dip-coated 15 times with a Krytox 157FSH-doped Teflon AF 2400 solution (10 
mg/mL) in FC-72 (0 and 50% (w/w) Krytox in Teflon AF). For each of the 15 “dips”, the fibers 
were immersed into the solution, then quickly removed after 2 seconds and dried in the air for 1 
minute to evaporate the FC-72.  Before use, each F-SPME fiber was exposed in a Thermo Focus 
GC inlet for conditioning at 250 °C for 30 min with a constant split flow of 60 mL/min and a 
split ratio of 20. Krytox 157FSH is thermally stable and does not desorb in the inlet of the gas 
chromatograph. The GC injection splitter was opened during the conditioning step to reduce the 
amount of impurities getting to the column. A commercially available SPME fiber with a 
polydimethylsiloxane (PDMS) coating (Sigma Aldrich, Bellefonte, PA) was used as a control to 
compare with those fibers with fluorous coatings. It was used at the same conditioning and GC 
conditions as the Krytox doped Teflon films.  
For the F-SPME extraction, the fibers were exposed to either the headspace or the liquid 
phase of a tris buffer solution (pH = 8.0) containing 100 μM quinoline and 100 μM phenol. GC 
conditions: were 250 °C inlet temperature, 100 °C initial oven temperature, hold 0.5 min, ramp 
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120 °C/min to 250 °C, hold 0.1 min, 60 mL/min split flow, split ratio = 20, in a 30 m long, 0.32 
mm ID Rxi-5ms column (df = 0.25 μm) (Restek, Bellefonte, PA).  
Peak areas obtained from the integrated chromatograms were used for quantitation. The 
calibration curves were first carried out for both quinoline and phenol standard solutions, 
respectively. The amount of the compound was correlated to the corresponding peak area. 
Standard solutions were first prepared and injected to determine the linearity and limit of 
quantitation (LOQ) for quinoline and phenol. Good linearity has been observed for quinoline in 
the weight range of 0.33 ng (LOQ) to 25 ng, with a correlation coefficient close to unity 
(R
2
>0.9999). Good linearity has also been found for phenol in the weight range of 0.22 ng (LOQ) 
to 20 ng, with a correlation coefficient close to unity (R
2
>0.9999). Selectivity of quinoline over 
phenol was described as the ratio of the extracted amounts.    
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4.3 RESULTS AND DISCUSSION 
4.3.1 96-well Vessel SPME 
 
Figure 4.3 Percentage of quinoline extracted as a function of time for Teflon AF films with different 
percentages of receptor doped. 
A kinetic study was first carried out to determine the time needed to reach equilibrium for 
the extraction of quinoline from the aqueous solution to Teflon AF films with different 
percentage of receptor doped. As shown in Figure 4.3, ten hours were sufficient. There was 
almost no extraction of quinoline into a Teflon AF film without the receptor. The equilibrium 
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time for that film was less than 1 hour. Based on the kinetic data, all other distribution 
experiments were allowed to equilibrate for ten hours. 
As illustrated in Figure 4.3, the Krytox-doped Teflon AF films extract a significant 
percentage of quinoline from the aqueous phase, suggesting that hydrogen bonding between 
quinoline and the fluorous carboxylic acid also occurs in the polymer phase as it does in a 
fluorous liquid phase[91]. The data also show that the receptor concentration had an effect on the 
extraction efficiency.  
  
 
Figure 4.4 Log Dpw of quinoline as a function of Krytox concentration in Teflon AF films for quinoline with 
an initial aqueous concentration of 50 μM. 
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We then carried out a more detailed study about the influence of the receptor 
concentration on the distribution coefficient. As shown in Figure 4.4, log D of quinoline 
partitioning into the pure Teflon AF film is small. The polymer-water distribution coefficient of 
quinoline increases with higher receptor concentration in the film, but the trend is reversed when 
there is more than 50% (w/w) receptor in the film. Therefore, the highest polymer-water 
distribution coefficient appears at Teflon AF film with 50% Krytox (w/w), which corresponds to 
a receptor concentration of 194 mM. At this optimal concentration and at equilibrium, 97.4% of 
the quinoline initially in the aqueous phase was extracted into the receptor doped fluorous film 
from the aqueous phase. In fact, as we describe later, the extraction is so effective that the 
distribution coefficient becomes dependent on the concentration of the analyte. In order to 
further elaborate the data, we have derived a theoretical model as below.  
The distribution of the free solute between the fluorous polymer film phase and the 
aqueous phase is determined by the distribution coefficient D0: 
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0       Equation 4.3 
where [S]aq and [S]f are the free solute concentration in the aqueous phase and film phase, 
respectively. When the receptor is added to the polymer film phase, solute and receptor forms a 
complex and the binding constant is defined as: 
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where n is the stoichiometry, [L]f is the free receptor concentration and fnLS ][   is the solute-
receptor complex concentration in the polymer phase. When the receptor is present in the 
polymer phase, the apparent solute distribution coefficient Dapp is: 
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Dividing Equation (4.5) by Equation (4.3):  
   
f
fnapp
S
LS
D
D
][
][
1
0

      Equation 4.6 
After rearranging Equation (4.6) and inserting it into Equation (4.4), we obtain: 
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After converting Equation (4.7) into the logarithmic form and rearranging it, we get  
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The free receptor concentration in the polymer film [L]f can be expressed as a relationship to the 
initial receptor concentration CL according to mass balance:            
                                                fnLf LSnCL ][][                   Equation 4.9 
After inserting Equation (4.9) into the Equation (4.8), we obtain 
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According the data in Figure 4.4, when [L]f = 0 (i.e., 0% Krytox) , the free solute concentration 
in the film, [S]f  is about 10
1.4
 or 25 times higher than the aqueous concentration. The large 
increase in Dapp upon addition of Krytox, up to values near 10
4
, is due to the formation of the 
complex, S·Ln. Therefore, in the presence of the ligand, Krytox, the analyte in the film is mostly 
in the form of the complex, S·Ln, the concentration of which is much larger than [S]f.  We can 
obtain an estimate of the binding constant and stoichiometry based on Equation 4.10 using an 
iteration method (Microsoft Excel Goal Seek). The stoichiometry was determined to be 1.2 and 
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binding constant is 2.7 x10
3
 M
-1
, suggesting that 1:1 complexation dominates in the polymer 
phase. 
Quinoline and Krytox 157FSH have been reported to form 1:1, 1:2, and 1:3 complexes 
(base : acid) in a fluorous liquid, FC-72[98]. The formation constant of quinoline-Krytox 
complex in the fluorous polymer phase is much smaller than the reported binding constant in a 
fluorous liquid, FC-72 (1.8 x 10
8
 M
-1
)[98]. This observation is consistent with the reported 
results that binding constant of Krytox and 3-hydroxypyridine complex (840 M
-1
) in Teflon AF 
was significantly smaller than that (3 x 10
6
 M
-1
) in FC-72 [27]. Although the number of data is 
limited, it appears that the fluorous polymer phase and the fluorous liquid phase are considerably 
different.  
A pair of carboxylic acids, such as Krytox can form a cyclic dimer at high 
concentrations[91]. Self-association is more prevalent at high concentrations than low 
concentration[87]. Previous study[87] shows the similar trend as ours that self-association of a 
molecular receptor in poor solvent decreases its binding efficacy[87]. In our study, quinoline-
receptor formation competes with the self-association of the receptor. This may explain the 
decreased distribution coefficient when high concentration of the receptor existed.  
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Figure 4.5 Polymer-water distribution coefficient of quinoline as a function of the initial quinoline 
aqueous concentration. 
The distribution coefficient is quite large, nearly 104, with 50% Krytox. With such a 
large distribution coefficient based on a specific molecular interaction, it is quite possible that the 
distribution coefficient depends on the initial solute concentration behavior. Thus, we determined 
quinoline distribution behavior over a wide range of initial quinoline concentrations to determine 
the concentration dependence. As shown in Figure 4.5, distribution coefficient decreases as the 
initial quinoline concentration increases. The trend can be explained by Equation (4.10), where 
D0, K, n, and CL are constants in this study. The increase of quinoline initial concentration leads 
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to the increase of [S·Ln]f, thus the decrease of the distribution coefficient Dapp, which is consistent 
with the findings in Figure 4.5.  
Selectivity of quinoline over its non-heterocyclic counterpart was studied. Phenol has 
been chosen as a good control because it is aromatic, it has a similar lipophilicity as quinoline 
but it does not contain the nitrogen. It also shows good solubility in water as well as a variety of 
organic solvents[99]. Importantly, the addition of fluorous carboxylic acids to fluorous liquid 
(FC-72), which dramatically increases pyridine distribution to the fluorous phase has no 
measureable effect on the distribution of phenol[91].  
 
Table 4.1 Distribution coefficients and selectivity for quinoline and phenol in pure Teflon AF and Teflon AF 
with 50% Krytox 
 Dpw(pure Teflon vs. Aqueous) Dpw(Teflon+50%Krytox vs. Aqueous) 
Phenol 4.5 130 
Quinoline 25 7640 
Selectivity 5.5 59 
 
 
Table 4.1 reveals the distribution coefficients of quinoline and phenol at initial solute 
concentration of 50 µM in pure Teflon AF and Teflon AF with 50% Krytox. The receptor-doped 
Teflon AF film shows a higher selectivity, 59, for quinoline over phenol while the pure Teflon 
AF film without receptor only shows a selectivity of 5.5. The significant improvement on 
selectivity demonstrates the effective hydrogen bonding of fluorous carboxylic acid group and 
nitrogen heterocyclic compound in the fluorous polymer medium.   
Compared to the previous reported receptor doped fluorous liquid-liquid extraction[91], 
this 96-well vessel SPME shows some advantages. As a green analytical method, this solvent-
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free extraction technique minimizes waste and human exposure to hazardous solvents. This 
SPME method requires small amount of sample, and it operates in parallel.  
The effects of receptor and solute concentration on the distribution coefficient and 
selectivity based on 96-well vessel SPME have been discussed as above. We then coated this 
receptor doped fluorous polymer on a stainless steel fiber as the coated fiber SPME. 
4.3.2 Coated Fiber SPME 
Coated fiber SPME is the most widely used SPME configuration. SPME is usually 
performed by either direct extraction in the liquid phase or headspace extraction. In the direct 
extraction mode, the coated fiber is inserted into the sample matrix to extract analytes into the 
extraction phase. In the headspace extraction mode, the fiber is inserted into the gaseous 
headspace above the sample matrix to extract those relatively volatile analytes. In order to 
compare feasibility of those modes, we first exposed the SPME fiber made from 50% 
Krytox/Teflon AF to both the liquid phase and the headspace of aqueous quinoline solutions. 
The fibers were then exposed at the GC inlet where the quinoline was desorbed. The peak areas 
were used for quantitation. Figure 4.6 shows the effect of quinoline initial concentration on 
SPME extraction based on both liquid phase and headspace exposure. For liquid phase 
extraction, it shows a linear relationship with a correlation coefficient close to unity (R
2
 = 0.999) 
and a slope of 0.0259 ng/M. The detection limit was calculated to be 34.9 µM based on the 
standard deviation and the slope of the regression line.  
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Figure 4.6 Quinoline amount extracted in both liquid phase and headspace as a function of quinoline initial 
concentration. 
 
For headspace extraction, a linear trend was found in the concentration range of 0 to 250 
μM with a correlation coefficient close to unity (R2 = 0.9997) and a slope of 0.00761 ng/M. 
The detection limit was determined to be 8.54 µM calculated by the standard deviation and the 
slope of the regression line. The proportional relationship between the extracted amount and the 
initial concentration can be described as the following equation for large sample volumes[6,7]: 
                                   0)]exp(1[ CVKtan ffs                                                 Equation 4.11 
where n is the amount of analyte extracted, Kfs is the distribution coefficient of the analyte 
between the fiber coating and the sample matrix, Vf is the volume of extraction phase, and C0 is 
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the initial concentration of the analyte, which is quinoline in this case, t is the exposure time, a is 
a parameter measuring how fast partition equilibrium can be reached, which is a constant for a 
constantly agitated system. According to Equation (4.11), the amount of analyte extracted is 
proportional to the initial analyte concentration once the sampling time and agitation conditions 
are held constant, which is consistent with the results shown in Figure 4.6. Therefore, the 
quantitative analysis of SPME is feasible even before partition equilibrium is reached. 
Both liquid phase direct extraction and headspace modes were feasible for quantitative 
analysis before equilibrium. The detection limit was lower in the headspace extraction than the 
liquid phase, which may due to less matrix interference in the headspace mode. This led us to 
choose headspace mode for selectivity experiments. Thus coated fibers were exposed to the 
headspace of an aqueous solution containing 100 µM quinoline and phenol in Tris buffer (pH = 
8.0) for 2 minutes and analyzed by GC.   
Compared to the PDMS fiber, which is a commonly used SPME fiber, the fluorous 
receptor doped Teflon AF coating shows a higher selectivity of 11.1 compared to 3.8 for 
quinoline over phenol. The pure Teflon AF film also shows slightly higher selectivity (5.3 versus 
3.8) than the pure PDMS film. Teflon AF 2400 has been found to contain one carboxylic acid 
group per 854 monomer units[100]. This may explain the slightly favored extraction of quinoline 
into the receptor-free Teflon AF film than PDMS. While the fiber-based selectivity using 50% 
(w/w) Krytox in Teflon AF coated fibers shows selectivity for quinoline (11.1), the selectivity is 
not as high as for the 96-well plate method (59). About a factor of two of this difference can be 
explained by the Henry’s law constants of the analytes. Quinoline has a higher Henry’s law 
constant (3700 mol/(kg*bar)) compared to phenol (1900 mol/(kg*bar))[101]. In addition, the 96-
well vessel SPME experiments were carried out at equilibrium while the coated fiber SPME 
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experiments were performed before equilibrium to simplify and speed up the extraction process. 
Thus, we did a kinetic study for quinoline and phenol by a SPME fiber coated by Teflon AF with 
50% Krytox as illustrated in Figure 4.7. The extracted amount of quinoline linearly increases 
with the exposure time while the extracted amount of phenol was almost zero due to no binding 
with the receptor. Further, the phenol amount extracted is at a plateau while the quinoline 
amount extracted is not. Thus, the selectivity actually increases when extraction time increases. 
This leads to a practical tradeoff – one can achieve high selectivity but at the cost of time. 
 
Figure 4.7 Kinetic profile of extracted quinoline amount by the coated fiber (50% Krytox in Teflon 
AF) SPME-GC at different headspace exposure times. 
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4.4 CONCLUSIONS 
We have demonstrated the distribution of a heterocyclic nitrogen-containing compound 
between Krytox 157 FSH doped Teflon AF 2400 films and buffered aqueous solution based on 
hydrogen bonding of the heterocyclic nitrogen group with the carboxylic acid group. We studied 
in both 96-well vessel SPME and the coated fiber SPME formats. The effects of receptor 
concentration and solute concentration on the extraction were studied. Those novel fluorous 
SPME devices in both 96-well vessel format and the coated fiber design show selectivity for a 
heterocyclic nitrogen-containing compound compared to its non-heterocyclic counterpart. Those 
novel receptor-doped fluorous SPME devices show great potential to detect quinoline-like 
potential environment pollutants in river water or other aqueous media. 
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